CSIMarket
 
Lensar Inc   (LNSR)
Other Ticker:  
 
 
Price: $4.0700 $0.19 4.897%
Day's High: $4.3041 Week Perf: -1.69 %
Day's Low: $ 3.79 30 Day Perf: -9.05 %
Volume (M): 12 52 Wk High: $ 5.30
Volume (M$): $ 47 52 Wk Avg: $3.21
Open: $3.87 52 Wk Low: $1.80



 Market Capitalization (Millions $) 49
 Shares Outstanding (Millions) 12
 Employees -
 Revenues (TTM) (Millions $) 40
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Lensar Inc
Lensar Inc. is a medical technology company that specializes in developing and manufacturing advanced laser systems for cataract surgery and other ophthalmic procedures. The company's flagship product is the Lensar Laser System, which integrates precise imaging and measurement technologies with femtosecond laser technology to improve the precision and outcomes of cataract surgeries. The Lensar Laser System offers surgeons improved control and accuracy during procedures, leading to faster recovery times and better patient outcomes. The company aims to innovate and advance ophthalmic care by developing cutting-edge technologies and providing reliable solutions for eye surgeons globally.


   Company Address: 2800 Discovery Drive Orlando 32826 FL
   Company Phone Number: 536-7271   Stock Exchange / Ticker: NASDAQ LNSR
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Lensar Inc

Lensar Inc: Defying the Odds with Exceptional Performance in Challenging Times



In the ever-changing world of finance, Lensar Inc has managed to navigate the challenges with resilience and determination. Despite the recent decline in its stock price, the company's latest financial results reveal a promising turnaround. Let's examine Lensar Inc's recent performance and put it into context against its financial results and stock movements.
Improvement in Earnings and Per Share Loss:
Lensar Inc showcased its capability to manage losses and improve its financial position during the July to September 30, 2023 financial period. Compared to the previous year, the company successfully decreased its loss per share from $-0.39 to $-0.23. Furthermore, Lensar Inc's income per share also demonstrated improvement, moving from $-0.81 per share in the preceding reporting period to its current $-0.23 per share.

Lensar Inc

Lensar Inc Outshines Competitors with Astonishing 49.44% Revenue Surge in Q2 2023

Lensar Inc, a medical equipment and supplies company, recently reported their second-quarter earnings for 2023. While the company experienced a shortfall per share of $-0.81, which is a decrease compared to the same period last year, their revenue surged by an impressive 49.44% to $12.01 million. In comparison to their peers in the medical equipment and supplies sector, Lensar Inc's revenue growth was higher.
During the second quarter of 2023, the average revenue rise for the two other companies in the medical equipment and supplies sector was only 4.51% compared to the same period in 2022. This highlights Lensar Inc's performance as they were able to achieve a much higher revenue growth rate.

Lensar Inc

Medical Technology Company Lensar Inc. Sees Improvement with $0.40 per Share Loss in Q1 2023, Revenue Declines 11.649% to $8.25 Million

In the first quarter of 2023, medical technology company Lensar Inc. reported a loss of $0.40 per share, an improvement from the $0.67 loss per share reported in the same period the year before. However, losses had increased from the prior reporting season where the loss per share was $0.22. The revenue also saw a decline of 11.649% to $8.25 million compared to $9.34 million from the year before. Sequentially, the revenue fell by 19.351% from $10.23 million.
A net loss of $4.272 million was reported for the first quarter of 2023, compared to a $6.674 million loss in the same period the prior year. The company is expected to release its next financial results on August 07, 2023.






 

Lensar Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com